Completed
A key objective of medicines regulatory authorities is to protect public health by ensuring the quality, safety and efficacy of medicines. Medicines regulatory authorities use mutual recognition/reliance agreements and informal practices of recognition/reliance in various range and approaches. At the request of the U.S. Food and Drug Administration's Office of International Programs, the National Academies have convened a committee to analyze and assess how the regulatory authorities of different countries use such regulatory practices and will evaluate their effects on public health, use of resources, and essential regulatory competencies.
Events
Events
Right Now & Next Up
Stay in the loop with can’t-miss sessions, live events, and activities happening over the next two days.
TRB Annual Meeting | January 11 - 15, 2026
January 11 - 15, 2026 | The TRB Annual Meeting brings together thousands of transportation professionals worldwide for sessions across all modes and sectors.